Literature DB >> 25471030

Lower mean corpuscular hemoglobin concentration is associated with unfavorable prognosis of resected lung cancer.

Xiao Qu1, Tiehong Zhang, Honghai Ma, Ping Sui, Jiajun Du.   

Abstract

BACKGROUND: The association of preoperative red blood cell indexes in non-anemic patients undergoing lung resections for non-small-cell lung cancer with recurrence-free survival (RFS) and overall survival (OS) has never been investigated.
METHODS: We retrospectively examined the impact of preoperative red blood cell indexes on RFS and OS and the relationships between the indexes and clinicopathological factors in lung cancer.
RESULTS: A total of 649 patients were evaluated. The mean corpuscular hemoglobin concentration was showed as an independent prognostic factor in all patients for OS (hazard ratio [HR]: 0.697; 95% CI: 0.502-0.969; p = 0.032) and RFS (HR: 0.688; 95% CI: 0.519-0.914; p = 0.010). The mean corpuscular volume was an independent prognostic factor in all patients for OS (HR: 0.589; 95% CI: 0.380-0.912; p = 0.018), but not for RFS (HR: 0.684; 95% CI: 0.461-1.015; p = 0.059).
CONCLUSION: In conclusion, the results of this study suggest that mean corpuscular hemoglobin concentration is an independent prognostic factor for OS and RFS in non-small-cell lung cancer.

Entities:  

Keywords:  MCHC; MCV; lung cancer; survival

Mesh:

Year:  2014        PMID: 25471030     DOI: 10.2217/fon.14.121

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  15 in total

1.  Impacts of Mycoplasma loads and lung lesions on immune and hematological statuses of pigs in an eight-breed cross heterogeneous population.

Authors:  Qing Zhang; Jing Li; Tao Huang; Yifeng Zhang; Wenwu Xu; Lusheng Huang; Huashui Ai; Bin Yang
Journal:  J Anim Sci       Date:  2020-08-01       Impact factor: 3.159

2.  The mean corpuscular volume as a prognostic factor for colorectal cancer.

Authors:  Hidemasa Nagai; Norihiro Yuasa; Eiji Takeuchi; Hideo Miyake; Yuichiro Yoshioka; Kanji Miyata
Journal:  Surg Today       Date:  2017-08-09       Impact factor: 2.549

3.  A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer.

Authors:  Shuhui Cao; Yao Zhang; Yan Zhou; Wenwen Rong; Yue Wang; Xuxinyi Ling; Lincheng Zhang; Jingwen Li; Yusuke Tomita; Satoshi Watanabe; Takeo Nakada; Nobuhiko Seki; Toyoaki Hida; Said Dermime; Runbo Zhong; Hua Zhong
Journal:  Transl Lung Cancer Res       Date:  2022-04

4.  Significance of Pretreatment Red Blood Cell Distribution Width in Patients with Newly Diagnosed Glioblastoma.

Authors:  Ruo-Fei Liang; Mao Li; Yuan Yang; Qing Mao; Yan-Hui Liu
Journal:  Med Sci Monit       Date:  2017-07-01

5.  A prospective cohort examination of haematological parameters in relation to cancer death and incidence: the Busselton Health Study.

Authors:  Niwansa Adris; Anita Chai Geik Chua; Matthew William Knuiman; Mark Laurence Divitini; Debbie Trinder; John Kevin Olynyk
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

6.  The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.

Authors:  Yaqi Huang; Siqi Wei; Nan Jiang; Lijuan Zhang; Siyuan Wang; Xiaona Cao; Yue Zhao; Peiguo Wang
Journal:  BMC Cancer       Date:  2018-12-10       Impact factor: 4.430

7.  High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma.

Authors:  Fei Han; Wenbin Liu; Hualiang Xiao; Yan Dong; Lei Sun; Chengyi Mao; Li Yin; Xiao Jiang; Lin Ao; Zhihong Cui; Jia Cao; Jinyi Liu
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

8.  Significance of NLDA, the commixed index of inflammation, immune responses, hemostasis, and nutrition, for predicting metastatic non-small cell lung cancer prognosis and metastases.

Authors:  Wen-Wen Sun; Jia-An Hu; Wen-Quan Niu; Bei-Li Gao; Zhi-Hong Xu
Journal:  Oncotarget       Date:  2017-05-23

9.  [Retrospectively Analysis of Factors Influencing the Relapse (or Progression) of Newly Diagnosed Nonoperative Small Cell Lung Cancer].

Authors:  Yaqin Zhuang; Liyan Jiang; Yizhuo Zhao; Jialin Qian; Xiwen Gao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2015-09-20

10.  An Applicable Inflammation-Joined and Nutrition-Related Prognostic Indicator in Patients With Colorectal Cancer.

Authors:  Guo Wu; Jungang Liu; Haizhou Liu; Lan Jin; Xiaoliang Huang; Xianwei Mo; Huage Zhong; Yanhua Li; Yawei Zhang; Weizhong Tang
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.